Menu
Fatty Acids Supplements Market Size Analysis
According to a recent survey conducted by ChemView Consulting, the Global Fatty Acids Supplements Market grew at a CAGR of 6.5% between 2017-2021 and is estimated to be US$ 4,274.6 Mn in 2022. Currently, the market is anticipated to grow at a CAGR of 7.4% and is expected to reach a valuation of US$ 8,728.5 Mn by 2032 end.
Fatty acid supplements have benefited from the rise in popularity of healthy lifestyles. Persistence Market Research analysts have closely examined the market to evaluate its growth and expectations for the near future.
Market Dynamic
INCREASING POPULARITY OF DIETARY SUPPLEMENTS AND OMEGA-3 FATTY ACIDS AID MARKET GROWTH
Omega-3 Supplements The market is expanding as nutritional supplements, and omega-3 fatty acids gain popularity. The prognosis for the business will be further improved by increased customer awareness of a healthy lifestyle and diet.
Omega-3 fatty acids, such as eicosapentaenoic acid (EPA), alpha-linolenic acid (ALA), and docosahexaenoic acid (DHA), are becoming more and more popular. These oils come from plants, including soybean, flaxseed, salmon, and canola. Several studies have also demonstrated the protective effects of consuming fatty fish and other seafood on heart health.
PROCESS-RELATED CHALLENGES IMPEDE MARKET GROWTH
The most important marine sources of the product are fish and krill. Over the past few years, the method for obtaining omega-3 from marine sources has changed. Producers encounter a few process-related difficulties that restrain the market’s expansion. Marine-derived omega-3 has a fishy taste and smell, which makes for a bad sensory experience. These fatty acids can alter the flavor balance of functional foods.
High processing temperatures may also have an impact on the product’s quality. Omega-3 fatty acids are obtained from marine sources by the extraction and purification of waste, and the contamination of the derived product may reduce its purity.
TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
The constant advancements in technology that boost the delivery and absorption of omega-3 fatty acids in the body are one of the main drivers of market expansion. Due to their bioavailability and variable absorption rate, the development of lipid-based supplements continues to be difficult. Numerous studies indicate that several factors may restrict the body’s ability to absorb omega fatty acids. The major market participants are pouring a lot of money into research and development to incorporate technology that will increase the body’s ability to absorb omega-3.
Covid-19 Impact
The global market has benefited from the COVID-19 epidemic. There have been claims of an enormous rise in demand for foods and dietary supplements containing omega fatty acids to improve health and immunity. The general recommendation from medical professionals worldwide to include immunity-boosting dietary supplements in daily living significantly influences how widely people utilize the product.
Companies in the sector have seen disruptions in their supply chains, mostly due to the current pandemic’s transit limitations and geometrically rising logistics and transportation costs. The slowdown in import and production of raw materials has disrupted the product’s manufacturing process.
Market Segments Covered in Report
By Source:
By Application:
By Region and Country:
Segment-Wise Analysis
Which source is estimated to account for the largest market share?
Marine Oils are estimated to account for the largest market share
Region-Wise Analysis
The regions analyzed for the market include North America, Europe, Latin America, Asia Pacific, Middle East, and Africa.
Competition Analysis
The global fatty acid supplements market is highly consolidated.
A list of some of the key suppliers present in the market are:
Report Coverage and Highlights
| Research Scope | Details |
| Forecast period | 2022-2032 |
| Historical data available for | 2017-2021 |
| Market analysis | USD Million for Value and Tons for Volume, and CAGR from 2022 to 2032 |
| Key regions covered | North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa |
| Key countries covered | US, Canada, Brazil, Mexico, Germany, Italy, France, UK, Spain, Netherlands, Norway, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Vietnam, Australia & New Zealand, Saudi Arabia, Turkey, UAE, South Africa, Nigeria, Egypt |
| Key segments covered | By Source, Application, Region, and Region |
| Customization scope | Available upon Request |
| Pricing and purchase options | Available upon Request |
Market Size Data
Market Background
Pricing Analysis
Value Chain Analysis
Competition Analysis
Country Coverage
North America: U.S., Canada
Latin America: Brazil, Mexico, Argentina, Central America, Rest of Latin America
Western Europe: Germany, Italy, France, UK, Spain, Poland, Romania, Rest of Western Europe
Eastern Europe: Russia & Belarus, Balkan Countries, Baltic Countries, Central Asia, Rest of Eastern Europe
Middle East & Africa: KSA, UAE, Turkey, Israel, Northern Africa, South Africa, Rest of Middle East & Africa
East Asia: China, Japan, South Korea
South Asia & Pacific: India, ASEAN, Australia & New Zealand, Rest of South Asia & Pacific
Why Choose CVC Market Research?;
In the forecast period between 2022 and 2032, the market is expected to grow at a CAGR of 7.4%.
The fatty acid supplements market size is growing with the increasing popularity of dietary supplements and omega-3 fatty acids.
Major global Fatty Acids Supplements Market players are Koninklijke DSM N.V, Croda Health Care, Copeinca AS., Omega Protein Corporation, Axellus AS, Arista Industries, and Dean Foods.
Organoleptic properties and other process-related challenges impede the market growth.
Asia Pacific Region is expected to account for the largest market revenue share in the Global Fatty Acids Supplements market.
Safe & Secure Payments
Facing issues finding the exact research to meet your business needs? Let us help you! One of our Research Executives will help you locate the research study that will answer your concerns.
Speak to Analyst